Barbara Duncan
DirectoratHalozyme Therapeutics· In proxies 2023–2025
Barbara Duncan sits on 9 public boards.
Experience
- Halozyme TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +128%
- Atea Pharmaceuticals, Inc.Public company
- Director? – PresentNo stock prices for these years
- Adaptimmune Therapeutics, plcPublic company
- Director? – PresentNo stock prices for these years
- Aevi Genomics Medicine, Inc.Public company
- Director? – PresentNo stock prices for these years
- Fusion Pharmaceuticals, Inc.Public company
- Director? – PresentNo stock prices for these years
- Immunomedics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Innoviva, Inc.Public company
- Director? – PresentNo stock prices for these years
- Jounce Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- ObsEva S.A.Public company
- Director? – PresentNo stock prices for these years
- Recent Past Public Company Board ExperiencePublic company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?